Identifying affinity-and specificity-enhancing mutations in protein-protein complexes is useful for many biotechnological applications. Yet, accurate prediction of such mutations is a very challenging task. We developed an efficient computational method for such predictions based on the framework of a protein design program ORBIT. As a start, we optimized the energy function of this program to reproduce favorable interactions across the binding interface. We then developed an in silico saturated mutagenesis protocol that allows us to scan any binding interface with all natural amino acids and within minutes to predict the change in free energy of binding for each of the mutation. Mutations with the most favorable change in free energy of binding are selected for experimental testing. We experimentally validated our computational protocol in two biological systems that exhibit high and medium binding affinity. In the high-affinity complex between the enzyme acetylcholinesterase (AChE) and a snake toxin fasciculin (Fas), we identified a few Fas mutants that experimentally show even higher affinities for the enzyme and in some cases enhanced binding specificity towards one species of AChE. In a medium-affinity complex between matrix metalloproteinase (MMP) and its inhibitor, tissue inhibitor membrane protein 2 (TIMP-2), we identified a considerable number of mutations that enhance TIMP-2 binding affinity to a particular type of MMP, MT1-MMP and show reduced affinities to another type of MMP, MMP-9. Overall, our computational protocol greatly facilitates the discovery of affinity-and specificity-enhancing mutations and thus could be applied for design of potent and highly specific inhibitors of any protein-protein interaction.
Identifying affinity-and specificity-enhancing mutations in protein-protein complexes is useful for many biotechnological applications. Yet, accurate prediction of such mutations is a very challenging task. We developed an efficient computational method for such predictions based on the framework of a protein design program ORBIT. As a start, we optimized the energy function of this program to reproduce favorable interactions across the binding interface. We then developed an in silico saturated mutagenesis protocol that allows us to scan any binding interface with all natural amino acids and within minutes to predict the change in free energy of binding for each of the mutation. Mutations with the most favorable change in free energy of binding are selected for experimental testing. We experimentally validated our computational protocol in two biological systems that exhibit high and medium binding affinity. In the high-affinity complex between the enzyme acetylcholinesterase (AChE) and a snake toxin fasciculin (Fas), we identified a few Fas mutants that experimentally show even higher affinities for the enzyme and in some cases enhanced binding specificity towards one species of AChE. In a medium-affinity complex between matrix metalloproteinase (MMP) and its inhibitor, tissue inhibitor membrane protein 2 (TIMP-2), we identified a considerable number of mutations that enhance TIMP-2 binding affinity to a particular type of MMP, MT1-MMP and show reduced affinities to another type of MMP, MMP-9. Overall, our computational protocol greatly facilitates the discovery of affinity-and specificity-enhancing mutations and thus could be applied for design of potent and highly specific inhibitors of any protein-protein interaction.
